Results 251 to 260 of about 35,140 (296)
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Background R/R DLBCL is an aggressive malignancy with limited treatment options. Novel immunotherapies have improved outcomes in selected clinical‐trial populations, but their effectiveness in real‐world settings remains unclear. Their substantial costs also pose challenges for healthcare systems.
Josef Singer +2 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 3, March 2026.This systematic review investigates whether inequalities exist in the utilisation of tumour and ctDNA somatic mutation testing in solid tumours. The review concludes that, across tumour types, testing modalities and socio‐demographic factors, inequalities exist and require further exploration.
Sarah Rae +5 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Purpose Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) effectively treats high‐risk acute lymphoblastic leukemia (ALL), yet challenges persist due to post‐transplant relapse and conditioning regimen toxicities. The determination of an appropriate preconditioning regimen is critical to improving patient outcomes.
Xiaoyan Zhao +6 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Background Palliative care is essential to manage symptoms and end‐of‐life (EOL) quality, yet its utilisation in liver cancer remains poorly understood. This study examined sociodemographic and clinical characteristics associated with palliative care admission in the last 5 years of life for people with a death from liver cancer.
Rebecca J. Mitchell +5 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Der Nervenarzt, 2013
Psycho-oncology was written to assist oncologists, physicians, psychiatrists and other mental health clinicians, and hospital chaplains in understanding and offering supportive treatment to the more than 40% of individuals who will receive a cancer diagnosis during their lifetime.
Thomas N. Wise +2 more
+7 more sources
Psycho-oncology was written to assist oncologists, physicians, psychiatrists and other mental health clinicians, and hospital chaplains in understanding and offering supportive treatment to the more than 40% of individuals who will receive a cancer diagnosis during their lifetime.
Thomas N. Wise +2 more
+7 more sources
Harvard Review of Psychiatry, 2009
The psychosocial and psychiatric sequelae of cancer are highly prevalent, diverse, and challenging for clinicians to manage. A growing body of literature has generated methods for the reliable screening, assessment, and management of these sequelae, including the treatment of psychiatric disorders that may complicate the course of cancer.
William S, Breitbart, Yesne, Alici
openaire +2 more sources
The psychosocial and psychiatric sequelae of cancer are highly prevalent, diverse, and challenging for clinicians to manage. A growing body of literature has generated methods for the reliable screening, assessment, and management of these sequelae, including the treatment of psychiatric disorders that may complicate the course of cancer.
William S, Breitbart, Yesne, Alici
openaire +2 more sources
Psychopharmacology in Psycho-oncology
Current Psychiatry Reports, 2013Psychopharmacological intervention is a major clinical and research area in oncology and palliative care. Over the last 35 years, psychotropic drugs have been shown to have a number of important indications for the treatment of the most common psychiatric disorders, such as depression, anxiety, stress-related syndromes, severe adjustment disorders ...
CARUSO, Rosangela +3 more
openaire +3 more sources
2016
Psycho-oncologic care for glioma patients has two important aspects. First, clinical decision making regarding treatment of the tumor should reflect a sound balance between quality and quantity of life. Second, supportive care should be targeted at the symptoms that are most detrimental to perceived quality of life (QOL) of glioma patients, and of ...
Jaap C, Reijneveld, Terri S, Armstrong
openaire +2 more sources
Psycho-oncologic care for glioma patients has two important aspects. First, clinical decision making regarding treatment of the tumor should reflect a sound balance between quality and quantity of life. Second, supportive care should be targeted at the symptoms that are most detrimental to perceived quality of life (QOL) of glioma patients, and of ...
Jaap C, Reijneveld, Terri S, Armstrong
openaire +2 more sources